Clinical Trials Directory

Trials / Completed

CompletedNCT02606695

Comprehensive Spinal Alignment Planning Study

A Prospective Multicenter Study Evaluating the Clinical and Radiographic Outcomes of Thoracolumbar Spine Surgery When Comprehensive Sagittal Alignment Surgical Planning is Used

Status
Completed
Phase
Study type
Observational
Enrollment
306 (actual)
Sponsor
NuVasive · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A comprehensive approach to the evaluation of alignment in spinal surgery patients - through preoperative planning, intraoperative assessment, and postoperative confirmation - has not been well-studied. This study aims to assess the value of such planning through clinical and radiographic outcomes.

Detailed description

Preoperative planning using tools such as NuvaMapTM (NuVasive®, Inc., San Diego, CA) enable a surgeon to preoperatively evaluate these alignment parameters and simulate a patient-specific plan using a combination of procedures, techniques, and implants. Once in the operating room, realignment objectives can be verified from a lateral fluoroscopic image in real-time using NuvaMap O.R. (NuVasive, Inc.), a software application integrated with the NVM5® neuromonitoring platform (NuVasive, Inc.). This real-time verification allows for confirmation and subsequent changing of the plan as necessary. The objective of this study is to validate the utility and effectiveness of comprehensive surgical planning in restoring and preserving sagittal alignment through the collection of clinical and radiographic outcomes.

Conditions

Interventions

TypeNameDescription
DEVICENuvaMap O.R.Clinical imaging software used to assess intraoperative spinal alignment
DEVICENuvaMapClinical imaging software used to assess spinal alignment

Timeline

Start date
2016-03-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2015-11-17
Last updated
2025-12-22

Locations

15 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02606695. Inclusion in this directory is not an endorsement.